AllianceBernstein’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-74,000
| Closed | -$137K | – | 3329 |
|
|
2023
Q1 | $137K | Hold |
74,000
| – | – | ﹤0.01% | 2979 |
|
|
2022
Q4 | $82.1K | Buy |
74,000
+6,400
| +9% | +$7.1K | ﹤0.01% | 3131 |
|
|
2022
Q3 | $158K | Buy |
67,600
+2,500
| +4% | +$5.84K | ﹤0.01% | 3056 |
|
|
2022
Q2 | $197K | Buy |
65,100
+3,000
| +5% | +$9.08K | ﹤0.01% | 3027 |
|
|
2022
Q1 | $422K | Buy |
62,100
+200
| +0.3% | +$1.36K | ﹤0.01% | 2738 |
|
|
2021
Q4 | $517K | Hold |
61,900
| – | – | ﹤0.01% | 2717 |
|
|
2021
Q3 | $460K | Hold |
61,900
| – | – | ﹤0.01% | 2778 |
|
|
2021
Q2 | $421K | Buy |
61,900
+6,000
| +11% | +$40.8K | ﹤0.01% | 2876 |
|
|
2021
Q1 | $574K | Hold |
55,900
| – | – | ﹤0.01% | 2598 |
|
|
2020
Q4 | $391K | Hold |
55,900
| – | – | ﹤0.01% | 2699 |
|
|
2020
Q3 | $456K | Sell |
55,900
-600
| -1% | -$4.89K | ﹤0.01% | 2562 |
|
|
2020
Q2 | $390K | Buy |
56,500
+6,300
| +13% | +$43.5K | ﹤0.01% | 2747 |
|
|
2020
Q1 | $238K | Buy |
50,200
+8,100
| +19% | +$38.4K | ﹤0.01% | 2714 |
|
|
2019
Q4 | $368K | Hold |
42,100
| – | – | ﹤0.01% | 2680 |
|
|
2019
Q3 | $140K | Hold |
42,100
| – | – | ﹤0.01% | 3010 |
|
|
2019
Q2 | $208K | Buy |
42,100
+800
| +2% | +$3.95K | ﹤0.01% | 2948 |
|
|
2019
Q1 | $256K | Hold |
41,300
| – | – | ﹤0.01% | 2818 |
|
|
2018
Q4 | $139K | Hold |
41,300
| – | – | ﹤0.01% | 2940 |
|
|
2018
Q3 | $268K | Buy |
41,300
+1,600
| +4% | +$10.4K | ﹤0.01% | 2879 |
|
|
2018
Q2 | $304K | Buy |
39,700
+21,900
| +123% | +$168K | ﹤0.01% | 2801 |
|
|
2018
Q1 | $398K | Buy |
17,800
+4,200
| +31% | +$93.9K | ﹤0.01% | 2580 |
|
|
2017
Q4 | $173K | Buy |
13,600
+1,000
| +8% | +$12.7K | ﹤0.01% | 2892 |
|
|
2017
Q3 | $196K | Hold |
12,600
| – | – | ﹤0.01% | 2936 |
|
|
2017
Q2 | $177K | Buy |
+12,600
| New | +$177K | ﹤0.01% | 2996 |
|